Long-Term Effects of a Losartan-Compared With an Atenolol-Based Treatment Regimen on Carotid Artery Plaque Development in Hypertensive Patients With Left Ventricular Hypertrophy: ICARUS, a LIFE Substudy
dc.contributor.author | Fossum, Eigil | en_US |
dc.contributor.author | Olsen, Michael Hecht | en_US |
dc.contributor.author | Høieggen, Aud | en_US |
dc.contributor.author | Wachtell, Kristian | en_US |
dc.contributor.author | Reims, Henrik M. | en_US |
dc.contributor.author | Kjeldsen, Sverre E. | en_US |
dc.contributor.author | Ibsen, Hans | en_US |
dc.contributor.author | Wan, Ying | en_US |
dc.contributor.author | Julius, Stevo | en_US |
dc.date.accessioned | 2010-06-01T20:01:53Z | |
dc.date.available | 2010-06-01T20:01:53Z | |
dc.date.issued | 2006-03 | en_US |
dc.identifier.citation | Fossum, Eigil; Olsen, Michael Hecht; HØieggen, Aud; Wachtell, Kristian; Reims, Henrik M . ; Kjeldsen, Sverre E . ; Ibsen, Hans; Wan, Ying; Julius, Stevo (2006). "Long-Term Effects of a Losartan-Compared With an Atenolol-Based Treatment Regimen on Carotid Artery Plaque Development in Hypertensive Patients With Left Ventricular Hypertrophy: ICARUS, a LIFE Substudy." The Journal of Clinical Hypertension 8(3): 169-173. <http://hdl.handle.net/2027.42/73158> | en_US |
dc.identifier.issn | 1524-6175 | en_US |
dc.identifier.issn | 1751-7176 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/73158 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16522993&dopt=citation | en_US |
dc.format.extent | 162313 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Le Jacq Ltd. | en_US |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 2006 Le Jacq Ltd. | en_US |
dc.title | Long-Term Effects of a Losartan-Compared With an Atenolol-Based Treatment Regimen on Carotid Artery Plaque Development in Hypertensive Patients With Left Ventricular Hypertrophy: ICARUS, a LIFE Substudy | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Division of Hypertension, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI | en_US |
dc.contributor.affiliationother | From the Departments of Cardiology | en_US |
dc.contributor.affiliationother | Nephrology, | en_US |
dc.contributor.affiliationother | Ullevaal University Hospital, Oslo, Norway; the Departments of Clinical Physiology and Nuclear Medicine | en_US |
dc.contributor.affiliationother | Internal Medicine, | en_US |
dc.contributor.affiliationother | Glostrup University Hospital, Glostrup, Denmark; Merck Research Laboratories, Blue Bell, PA; | en_US |
dc.identifier.pmid | 16522993 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/73158/1/j.1524-6175.2006.04838.x.pdf | |
dc.identifier.doi | 10.1111/j.1524-6175.2006.04838.x | en_US |
dc.identifier.source | The Journal of Clinical Hypertension | en_US |
dc.identifier.citedreference | Lewington S, Clarke R, Qizilbash N, et al., For the Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360: 1903 – 1913. | en_US |
dc.identifier.citedreference | Ezzati M, Lopez AD, Rodgers A, et al., For the Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet. 2002; 360: 1347 – 1360. | en_US |
dc.identifier.citedreference | Kjeldsen SE, Westheim AS, Os I. INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study. Lancet. 2000; 356: 1929 – 1930. | en_US |
dc.identifier.citedreference | Dahl?f B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint Reduction in Hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002; 359: 995 – 1003. | en_US |
dc.identifier.citedreference | Olsen MH, Fossum E, Hjerkinn E, et al. Relative influence of insulin resistance versus blood pressure on vascular changes in longstanding hypertension. ICARUS, a LIFE substudy. Insulin Carotids US Scandinavia. J Hypertens. 2000; 18: 75 – 81. | en_US |
dc.identifier.citedreference | Olsen MH, Fossum E, H?ieggen A, et al. Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy. J Hypertens. 2005; 23: 891 – 898. | en_US |
dc.identifier.citedreference | Olsen MH, Wachtell K, Neland K, et al. Losartan but not atenolol reduce carotid artery hypertrophy in essential hypertension. A LIFE substudy. Blood Press. 2005; 14: 177 – 183. | en_US |
dc.identifier.citedreference | Hollander M, Bots ML, Del Sol AI, et al. Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: the Rotterdam study. Circulation. 2002; 105: 2872 – 2877. | en_US |
dc.identifier.citedreference | Brasier AR, Recinos A III, Eledrisi MS. Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol. 2002; 22: 1257 – 1266. | en_US |
dc.identifier.citedreference | Sun YP, Zhu BQ, Browne AE, et al. Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function. J Cardiovasc Pharmacol Ther. 2001; 6: 175 – 181. | en_US |
dc.identifier.citedreference | Schiffrin EL, Park JB, Intengan HD, et al. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation. 2000; 101: 1653 – 1659. | en_US |
dc.identifier.citedreference | Wiklund O, Hulthe J, Wikstrand J, et al. Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: a 3-year randomized study. Stroke. 2002; 33: 572 – 577. | en_US |
dc.identifier.citedreference | Howard G, Sharrett AR, Heiss G, et al. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC investigators. Stroke. 1993; 24: 1297 – 1304. | en_US |
dc.identifier.citedreference | Klemsdal TO, Moan A, Kjeldsen SE. Effects of selective angiotensin II type 1 receptor blockade with losartan on arterial compliance in patients with mild essential hypertension. Blood Press. 1999; 8: 214 – 219. | en_US |
dc.identifier.citedreference | Schieffer B, Schieffer E, Hilfiker-Kleiner D, et al. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation. 2000; 101: 1372 – 1378. | en_US |
dc.identifier.citedreference | Kr?mer C, Sunkomat J, Witte J, et al. Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179. Circ Res. 2002; 90: 770 – 776. | en_US |
dc.identifier.citedreference | Spence JD. Ultrasound measurement of carotid plaque as a surrogate outcome for coronary artery disease. Am J Cardiol. 2002; 89 ( 4A ): 10B – 16B. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.